Search PubMed⌕ Search

Biomedical subjects

E M Lee

Publications and source records attributed to E M Lee.

At least 37 records · Page 2Linked to original sources
PubMed1998

Microvascular integrity as a predictor of left ventricular remodeling after acute anterior wall myocardial infarction.

The purpose of this study was to investigate the relation of microvascular integrity and ventricular remodeling after acute myocardial infarction. Twenty-six patients with first acute anterior myocardial infarction were studied before discharge with myocardial contrast echocardiography (MCE). Opacification index (OI) and wall motion index were calculated in the left anterior descending artery territory and left ventricular diastolic volume was measured at baseline and during a 9-month follow-up. In total 26 patients, the regional wall motion improved but the left ventricular volume and global function was not changed significantly at follow-up. When the patients were divided into 3 groups according to opacification index (> or = 0.75, 0.5 approximately 0.75, < or = 0.5) at baseline, functional recovery was not observed and significant left ventricular dilatation was developed in patients with < or = 0.5 OI. Among the baseline echo-parameters such as ejection fraction, wall motion score, left ventricular volume and opacification index, the best predictor for long term left ventricular dilatation was the opacification index by multivariate analysis. In patients with acute anterior wall infarction the assessment of microvascular integrity by MCE at acute stage provides useful information regarding recovery of dysfunctional regional wall motion and ventricular remodeling.

Coronary Vessels↗
PubMed1997

Midterm results of mitral valve repair with the Sculptor annuloplasty ring.

BACKGROUND: The partly flexible Sculptor ring is more physiologic than the rigid Carpentier-Edwards ring and may improve outcome. METHODS: We studied 221 consecutive patients who underwent mitral valve repair for mitral regurgitation. The Sculptor ring was randomly implanted in 30 patients (Sculptor ring group) and the Carpentier-Edwards ring in 36 patients (Carpentier-Edwards ring control group) from 1993 to 1994. Before 1993, 155 patients received the Carpentier-Edwards ring (Carpentier-Edwards ring historical group). Baseline group characteristics were similar. RESULTS: Thirty-day mortality in the Sculptor ring, Carpentier-Edwards ring control, and Carpentier-Edwards ring historical groups was 0.0% versus 2.8% versus 3.2% (p = 0.61), respectively. At 18 months, survival was 86% +/- 6% versus 88% +/- 7% versus 90% +/- 3% (p = 0.89), and freedom from complications was 100% +/- 0% versus 100% +/- 0% versus 98% +/- 1% (p = 0.51) for endocarditis, 90% +/- 6% versus 94% +/- 4% versus 96% +/- 2% (p = 0.47) for severe mitral regurgitation, 93% +/- 5% versus 91% +/- 5% versus 92% +/- 2% (p = 0.91) for thromboembolism, and 77% +/- 8% versus 80% +/- 7% versus 82% +/- 3% (p = 0.49) for myocardial failure, respectively. CONCLUSIONS: The Sculptor ring is a safe alternative to the prosthetic annuloplasty rings in current use. The benefits of its physiologic design are either clinically insignificant or undetectable with a small sample size.

Aged↗
PubMed1997

Increasing the immunogenicity of a trivalent influenza virus vaccine with adjuvant-active nonionic block copolymers for potential use in the elderly.

High molecular weight nonionic block copolymers consisting of a large hydrophobic core made from repeat oxypropylene units and smaller hydrophilic blocks of oxyethylene repeat units were evaluated as adjuvants in experimental influenza virus vaccine formulations. The goal was to identify a copolymer that would increase the immunogenicity of the commercial Fluogen trivalent influenza virus vaccine. Vaccine experiments done using BALB/c mice provided data that allowed us to identify a copolymer that increased both antibody titers specific for total virus proteins as well as antibodies with hemagglutination inhibition (HAI) activity. This copolymer, termed CRL1005, increased the production of IgG1, IgG2a and IgG2b which suggested it increased the activity of both Type-1 and Type-2 T-helper lymphocytes. The CRL1005 copolymer was tested further in rhesus monkeys with similar results. Levels of antibodies specific for total virus protein preparations were increased as were HAI antibody titers following vaccination with the copolymer-supplemented Fluogen vaccine. Thus, the CRL1005 copolymer adjuvant appears to be compatible for use with the current generation of inactivated viron-based influenza vaccines and useful for increasing the immunogenicity. A more potent influenza virus vaccine could well be more efficacious in the aged segment of our population than current vaccines.

Adjuvants, Immunologic↗
PubMed1997

Superiority of mitral valve repair in surgery for degenerative mitral regurgitation.

OBJECTIVES: We aimed to assess the influence of type of operation on outcome in degenerative mitral regurgitation. METHODS: We compared outcomes in 278 consecutive patients who underwent mitral valve repair (167 patients), replacement with subvalvular preservation (22 patients) and without subvalvular preservation (89 patients) for degenerative mitral regurgitation. RESULTS: There was a trend towards lower mortality with repair and replacement with subvalvular preservation compared to replacement without subvalvular preservation. Thirty-day mortality was 1.2% vs 0.0% vs 4.7% (ns) respectively. Six-year survival was, respectively, 67.8 +/- 7.4% (P = 0.088) vs 80.8 +/- 11.0% (P = 0.25) vs 63.3 +/- 5.9% for all-cause death, 78.5 +/- 6.8% (P = 0.063) vs 95.5 +/- 4.4% (P = 0.092) vs 67.6 +/- 5.9% for all complication-related death and 80.5 +/- 6.9% (P = 0.076) vs 100.0 +/- 0.0% (P = 0.045) vs 72.8 +/- 5.8% for complication-related death due to myocardial failure. Multivariate analysis confirmed independent beneficial effects from repair compared to replacement without subvalvular preservation on complication-related death (hazard ratio 0.42, P = 0.010) and death from myocardial failure (hazard ratio 0.40, P = 0.014), and from repair compared to mechanical replacement on thromboembolism (hazard ratio 0.45, P = 0.029) and anticoagulation-related haemorrhage (hazard ratio 0.19, P = 0.026). CONCLUSIONS: Mitral valve repair is superior to replacement. The greatest survival advantage is in reduced mortality from myocardial failure. Repair should be the operation of choice for degenerative mitral regurgitation.

Aged↗
PubMed1997

Mitral valve surgery in the elderly.

BACKGROUND AND AIMS OF THE STUDY: Previous studies have shown that outcome from mitral valve surgery is poorer in the elderly. However, such studies did not distinguish between age itself, age-associated factors and interactions between age and other factors. We aimed to examine the relative influences of age and these other factors on outcome. METHODS: We compared outcomes from mitral valve repair or replacement in 190 elderly (> or = 70 years) and 424 younger (< 70 years) consecutive adult patients. RESULTS: At baseline, the elderly had more (p > 0.05) degenerative mitral regurgitation, coronary artery disease, left ventricular impairment, New York Heart Association (NYHA) class III or IV symptoms, bioprosthetic replacement and mitral valve repair. Operative mortality rate was low both in elderly (7/190 patients, 3.7%) and younger patients (15/424 patients, 3.5%, NS). Seven-year survival was poorer in the elderly with respect to overall survival, (49 +/- 6% vs. 72 +/- 3%, p = 0.0001), freedom from complications-related death (57 +/- 7% vs. 79 +/- 3%, p = 0.001), from death due to myocardial failure (66 +/- 6% vs. 86 +/- 3%, p < 0.0001) and from overt myocardial failure (44 +/- 7% vs. 74 +/- 3%, p = 0.0001). Multivariate analysis showed better survival with younger age, mitral valve repair, better preoperative NYHA class and better left ventricular function. However, 7-year freedom from complications-related death was excellent and similar in both elderly (90 +/- 7%) and younger (93 +/- 3%, NS) patients who underwent surgery early while in NYHA class I or II with left ventricular ejection fraction > 40%. CONCLUSIONS: Late surgery contributes far more than age itself to poor outcome from mitral valve surgery in the elderly. If surgery is performed early and repair preferred to replacement whenever feasible, medium-term results are excellent in both young and old.

Age Factors↗
PubMed1997

Echocardiography in mitral valve repair for mitral regurgitation: the surgeon's needs.

Mitral valve repair has become the operation of choice for mitral regurgitation. It is often technically more demanding than valve replacement. The role of echocardiography has now extended beyond the identification of severe mitral regurgitation that would benefit from surgical correction. It helps the surgeon to assess valve reparability preoperatively, to assess the need for valve surgery in equivocal cases of ischemic mitral regurgitation, to plan the operation, and to assess valve function after repair. This article aims to discuss the role of echocardiography in providing the information needed by the surgeon for successful mitral valve repair. The echocardiographer must understand the surgeon's needs, while surgeons should understand both the benefits and limitations of echocardiography.

Diagnosis, Differential↗
PubMed1996

Importance of subvalvular preservation and early operation in mitral valve surgery.

BACKGROUND: Mitral valve replacement (MVR) has a high mortality and morbidity. It has been suggested that preservation of the subvalvular apparatus and more optimal timing of surgery might improve outcome. METHODS AND RESULTS: We performed a retrospective study of 612 consecutive patients who underwent mitral valve repair or replacement: 226 patients had repair, 68 had replacement with subvalvular preservation (MVR/SVP), and 318 had replacement without subvalvular preservation (MVR/NoSVP). Baseline characteristics were most unfavorable in the repair group with respect to age (P = .002) and in the repair and MVR/SVP groups with respect to NYHA functional class and left ventricular function (P = .044). Thirty-day mortality was lower in the repair (1.8%, P = .046) and MVR/SVP (1.5%. P = NS) groups than the MVR/NoSVP group (5.0%). Overall survival at 7 years was better in the repair (71.2 +/- 5.6%. P = .022) and MVR/SVP (66.2 +/- 12.4%, P = .017) groups than the MVR/NoSVP group (63.5 +/- 3.4%). Myocardial failure caused 66 of 107 complication-related deaths. Multivariate analysis confirmed independent beneficial effects of repair on 30-day mortality (odds ratio, 0.27, P < .05) and of repair and MVR/SVP on overall mortality (hazard ratios, 0.43, P < .001 and 0.40, P < .05, respectively) and complication-related death hazard ratios, 0.38, P < .001 and 0.35, P < .05, respectively). Preoperative NYHA class III or IV symptoms and left ventricular impairment were independent risk factors for death and myocardial failure. CONCLUSIONS: Mitral valve repair is superior to replacement. If repair is not feasible, the subvalvular apparatus should be preserved. Early surgery before the development of severe symptoms and demonstrable left ventricular impairment is also needed to optimize outcome.

Aged↗
PubMed1995

Mortality and morbidity after mitral valve repair: the importance of left ventricular dysfunction.

A retrospective study of 219 consecutive patients who underwent mitral valve repair for mitral regurgitation or mixed mitral valve disease with at least moderate regurgitation was undertaken. The etiology was degenerative in 151 (68.9%) patients, endocarditis in 24 (10.9%), rheumatic in 22 (10.0%), ischemic in 13 (5.9%), congenital in five (2.3%) and cardiomyopathy in two (0.9%). The average age was 64.8 +/- 10.9 years, the average follow up 30.2 +/- 24.1 months. Pre-operatively, 74% were in NYHA functional class III or IV. Left ventricular function was assessed by angiography and echocardiography, and moderate or severe impairment (ejection fraction < or = 40%) was assumed to represent significant left ventricular dysfunction. There were six (2.7%) hospital deaths, four of which were due to left ventricular dysfunction. The seven-year mortality and seven-year combined mortality and morbidity were 14.4% and 37.1% respectively for complications related to left ventricular dysfunction, and 2.5% and 24.2% respectively for unrelated complications. Subgroup analysis showed that five-year mortality and five-year combined mortality and morbidity due to left ventricular dysfunction were significantly worse in patients who had pre-operative left ventricular dysfunction than those who did not: 28.5% vs. 6.1% (p < 0.001) and 52.4% vs. 17.8% (p < 0.001). There was nevertheless a significant incidence of postoperative left ventricular dysfunction in patients with satisfactory preoperative left ventricular function. In this group, five-year mortality and five-year combined mortality and morbidity due to left ventricular dysfunction were higher in patients who were in NYHA class III or IV preoperatively than in those who were not: 11.2% vs. 0% (NS) and 25.9% vs. 0% (p < 0.01) respectively, particularly if they also had early (3-10 days) post-operative left ventricular dysfunction: 20.4% (p < 0.001) and 41.7% (p < 0.001) respectively. Despite preservation of the mitral apparatus, left ventricular dysfunction remains a major cause of mortality and morbidity following mitral valve repair for mitral regurgitation.

Adolescent↗
PubMed1993

Intestinal parasite infections in the inhabitants along the Hantan River, Chorwon-gun.

The prevalence of intestinal parasite infections in inhabitants at the reaches of the Hantan River, Chorwon-gun, Korea, was observed from August 12 to September 14, 1993. Of 465 people observed by cellophane thick smear and formalin-ether concentration method, 2 Ascaris lumbricoides (unfertilized), 1 Trichuris trichiura, 39 Clonorchis sinensis and 16 Metagonimus egg positive cases were found. After treatment, the Metagonimus egg positive cases passed out flukes of Metagonimus Miyata type. Of 68 fish caught in the Hantan River, 14 (20.6%) were infected with metacercariae of Metagonimus, while no metacercaria of C. sinensis was found. At this area, soil-transmitted nematodes are very low, but clonorchiasis and metagonimiasis are prevalent by modernate endemicity.

Adolescent↗
PubMed1993

Effect of a single Lernaeocera branchialis (Copepoda) on growth of Atlantic cod.

A study was conducted to determine the influence of controlled water temperature on growth rate of Atlantic cod (Gadus morhua) after infection with a single, blood-feeding copepod, Lernaeocera branchialis. Initially, uninfected and infected fish were held in ambient seawater (0-10 C) in a raceway and fed to satiation from October to March. In a second trial simulating the water temperature at which cod live in winter (2-3 C), 2 groups of fish were kept in tanks through which sea water flowed, and they were fed to satiation from February through July. Infected cod held at the ambient temperature consumed more feed, had comparable weight-gain, and showed lower feed conversion efficiency (%) and k-factor than did control fish during autumn to early winter, whereas no difference was apparent during the remaining winter period. Also, no striking difference in feed consumed, weight gained, feed conversion efficiency or k-factor were apparent when the 2 groups of cod were held in heated sea water during winter to early summer. These results suggest that adult cod infected with 1 L. branchialis compensate for the infection in autumn rather than during winter by consuming more fed.

Analysis of Variance↗
PubMed1992

Single-center experience of unrelated living-donor renal transplantation in the cyclosporine era.

Renal transplantation from the unrelated living-donor might be an alternative when the cadaveric or related donor is not available, because graft and patient survival rates are superior to those of kidneys from cadaveric donors and even comparable to those from related donors. Among the many factors that might contribute to these excellent results, we believe that the good quality of kidneys (lacking preservation or ischemic injury) is the most important one. In addition, our criteria for patient selection requiring well-matched HLA typing might partially contribute to our success. For the successful renal transplantation program using unrelated-living donors, high ethical standards, accumulated experience from living-related donor transplantation, and dedicated professionalism are strongly recommended.

ABO Blood-Group System↗
PubMed1992

[Leukemia cutis: clinical and histopathological analysis of 14 cases].

We report 14 cases of leukemia cutis registered at Department of Dermatology, Veterans General Hospital Over a period of 18 years. There were one patient with acute lymphocytic leukemia (ALL), one with chronic lymphocytic leukemia (CLL), seven with acute monocytic leukemia (AMOL), one with acute myelomonocytic leukemia (AMML), and four with chronic myelocytic leukemia (CML). Multiple papules and nodules were the most frequent clinical lesions. Metastatic skin lesions occurred most commonly on legs (71%), followed by arms (64%), back (50%), anterior chest (50%), scalp (14%), and face (14%). The feet (7%) were rarely involved while palms and soles were rarely involved. Cutaneous leukemic lesions may be concomitant with or after, but never before the diagnosis of systemic leukemia in our series has had such change. In general, the histopathology of leukemia cutis showed diffuse or nodular infiltration of leukemic cells in the dermis and subcutaneous tissue, often typing of leukemia relays on more confirmative studies of peripheral smear and bone marrow biopsy. Leukemia cutis seems to be dissemination of systemic leukemia to the skin, and the presence of cutaneous leukemic lesions are associated with a very poor prognosis. Most patients (85%) died within 4 months after appearance of skin metastasis.

Adolescent↗
PubMed1991

Palmitate and stearate kinetics in the rat during sepsis and trauma.

Kinetics of plasma free palmitate and stearate were measured in control and septic-traumatized rats to determine the contribution plasma free fatty acids make to increased resting energy expenditure. Measurements were made at 24 hr after insult using a primed, 4-hr continuous infusion of selected (1-14C) fatty acid. The plasma concentration of palmitate was increased and stearate was decreased in sepsis-trauma rats compared to plasma concentrations in healthy control rats. Fatty acid turnover rates during sepsis-trauma were changed from control turnover rates in the same direction as plasma concentrations. Oxidation rates for palmitate and stearate at 24 hr after induction of sepsis-trauma were not different from oxidation rates in control rats. Plasma free fatty acids were concluded not to exhibit increased oxidation after sepsis-trauma and not to contribute extra energy during hypercatabolism. This finding contrasts with glucose and amino acids which have an increased oxidation rate during hypercatabolism.

Animals↗